CORRECTION article
Front. Neurosci.
Sec. Neurodegeneration
Volume 19 - 2025 | doi: 10.3389/fnins.2025.1639244
Correction: Fingolimod Inhibits Inflammation but Exacerbates Brain Edema in the Acute Phases of Cerebral Ischemia in Diabetic Mice
Provisionally accepted- Shanghai Jiao Tong University, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Correction: Fingolimod Inhibits Inflammation but Exacerbates Brain Edema in the Acute Phases of Cerebral Ischemia in Diabetic Mice* Correspondence: ytwang@sjtu.edu.cn or gyyang0626@163.comKeywords: Diabetic stroke, diabetes mellitus, fingolimod, edema, inflammation.Correction on: Wanlu Li, Tingting He, Lu Jiang, Rubing Shi, Yaying Song, Muyassar Mamtilahun, Yuanyuan Ma, Zhijun Zhang, Yaohui Tang, Guoyuan Yang*, Yongting Wang*. Fingolimod inhibits inflammation but exacerbates brain edema in the acute phases of cerebral ischemia in diabetic mice. Frontiers in neuroscience, 2020, 14: 842. Error in figure/tableIn the published article, there was an error in Figure 3C as published. The GAPDH western blot image in Figure 3C was unintentionally incorrectly used. The corrected Figure 3C and its caption ** Figure 3. Fingolimod increased Bcl-2/Bax ratio but did not reduce the number of TUNEL + cells at 24 h after tMCAO. (A), Micrographs of TUNEL staining in the peri-infarct region of DM + MCAO and DM + MCAO + F groups. Scale bar, 50 μm. Left panel showing the sketch of the brain section, boxes in it illustrating fields we are sampling in. (B), Bar graph is the quantification of the number of TUNEL+ cells in DM + MCAO and DM + MCAO + F groups (n = 3/group). (C), Western blot results of apoptotic factors Bcl-2 and Bax. (D), Bar graph is the quantification of Bcl-2/Bax ratio based on Western blot data [n (Sham) = 3, n (DM + MCAO) = 3, n (DM + MCAO + F) = 6]. MW, molecular weight. Data are presented as mean ± SEM, *p < 0.05, **p < 0.01. appear below.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.Text correctionIn the published article, there was an error. Citing data within the Results section.A correction has been made to Results, Acute Treatment with Fingolimod Failed to Improve Endpoint Outcomes at 24 h After tMCAO in Diabetic Mice, Paragraph 2-Reuslt of Figure 1G. This sentence previously stated:“brain infarction volume (DM + MCAO vs. DM + MCAO + F, 62.81 ±3.15 mm3 vs. 71.22 ±3.98 mm3) (Figures 1F–G) was observed.”The corrected sentence appears below:“brain infarction volume (DM + MCAO vs. DM + MCAO + F, 40.7 ± 8.90 mm3 vs. 34.4 ± 6.97 mm3) (Figures 1F–G) was observed.”The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Diabetic stroke, Diabetes Mellitus, fingolimod, Edema, Inflammation
Received: 01 Jun 2025; Accepted: 02 Jun 2025.
Copyright: © 2025 LI, He, Jiang, Shi, Song, Mamtilahun, Yuanyuan, Zhang, Tang, Yang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Guoyuan Yang, Shanghai Jiao Tong University, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.